Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fibrinolytic components of human uterine arterial and venous blood.

Literature DB >> 5602553

Fibrinolytic components of human uterine arterial and venous blood.

A V Mackay, P C Das, P R Myerscough, J D Cash.

Abstract

The fibrinolytic components of uterine arterial and venous blood were studied in 14 patients undergoing various obstetrical and gynaecological procedures. There was a highly significant higher concentration of plasminogen activator, as measured by the euglobulin lysis time, and fibrin degradation products in the uterine venous blood.

Entities: Species

Mesh：

Substances：

Year: 1967 PMID： 5602553 PMCID： PMC473473 DOI： 10.1136/jcp.20.3.227

Source DB: PubMed Journal: J Clin Pathol ISSN： 0021-9746 Impact factor: 3.411

24 in total

1. [PRODUCTION OF A FIBRINOLYTIC ACTIVATORS IN THE ISOLATED KIDNEY (FIBRINOLYTIC ACTIVATOR IN THE ISOLATED KIDNEY)].

Authors: K BULUK; M MALOFIEJEW
Journal: Acta Physiol Pol Date: 1963 Jul-Aug

2. FIBRINOLYSIS AND FIBRINOGEN BREAKDOWN PRODUCTS (ANTITHROMBIN VI) IN RENAL VENOUS BLOOD (RVB) IN DOG.

Authors: K WOROWSKI; S NIEWIAROWSKI; J PROKOPOWICZ
Journal: Thromb Diath Haemorrh Date: 1964-10-15

3. [BLOOD FIBRINOLYTIC ACTIVITY IN RELATION TO ANESTHESIA AND SURGICAL INTERVENTION].

Authors: R CUOCOLO; G ESPOSITO; N SPAMPINATO
Journal: Minerva Anestesiol Date: 1965-04 Impact factor: 3.051

4. Fibrinolysis induced by pressor amines.

Authors: E GENTON; F KERN; K VON KAULLA
Journal: Am J Med Date: 1961-10 Impact factor: 4.965

5. On the controlling function of the kidneys in fibrinolysis.

Authors: K BULUK; M FURMAN
Journal: Experientia Date: 1962-03-15

6. [Analysis, by immuno-chemical methods, of the degradation by plasmin of human fibrinogen and fibrin, at different stages].

Authors: V NUSSENZWEIG; M SELIGMANN
Journal: Nouv Rev Fr Hematol Date: 1960 Nov-Dec

7. A model of local fibrinolysis (marked elevation of fibrinolytic activity of blood obtained from vasa efferentia of the uterus).

Authors: M Maki; M Nagayama; K Sasaki; T Yoneya
Journal: Tohoku J Exp Med Date: 1965-06-25 Impact factor: 1.848

7. Investigations and preparation of fibrinogencoated tan A/Das PC: Investigations and preparation of fibrinogen-coated tanned sheep red cells.

Authors: P C Das
Journal: J Clin Pathol Date: 1970-03 Impact factor: 3.411

7 in total

Fibrinolytic components of human uterine arterial and venous blood.

1. [PRODUCTION OF A FIBRINOLYTIC ACTIVATORS IN THE ISOLATED KIDNEY (FIBRINOLYTIC ACTIVATOR IN THE ISOLATED KIDNEY)].

2. FIBRINOLYSIS AND FIBRINOGEN BREAKDOWN PRODUCTS (ANTITHROMBIN VI) IN RENAL VENOUS BLOOD (RVB) IN DOG.

3. [BLOOD FIBRINOLYTIC ACTIVITY IN RELATION TO ANESTHESIA AND SURGICAL INTERVENTION].

4. Fibrinolysis induced by pressor amines.

5. On the controlling function of the kidneys in fibrinolysis.

6. [Analysis, by immuno-chemical methods, of the degradation by plasmin of human fibrinogen and fibrin, at different stages].

7. A model of local fibrinolysis (marked elevation of fibrinolytic activity of blood obtained from vasa efferentia of the uterus).

8. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

9. The kidneys and the liver as the organs regulating the fibrinolytic system of the circulating blood.

10. Effect of moderate exercise on the fibrinolytic system in normal young men and women.

1. Serum fibrin degradation products throughout normal pregnancy.

2. Abnormal fibrinolysis.

3. Fibrin degradation products in normal and abnormal pregnancy and parturition.

4. Fibrin degradation products in sera of women with normal menstruation and menorrhagia.

5. Fibinolysis in colonic disease.

6. Assay of serum fibrin degradation products by agglutination-inhibition of coated erythrocytes.

7. Investigations and preparation of fibrinogencoated tan A/Das PC: Investigations and preparation of fibrinogen-coated tanned sheep red cells.